CXCL10 is upregulated in synovium and cartilage following articular fracture

Abstract

The objective of this study was to investigate the expression of the chemokine CXCL10 and its role in joint tissues following articular fracture. We hypothesized that CXCL10 is upregulated following articular fracture and contributes to cartilage degradation associated with posttraumatic arthritis (PTA). To evaluate CXCL10 expression following articular fracture, gene expression was quantified in synovial tissue from knee joints of C57BL/6 mice that develop PTA following articular fracture, and MRL/MpJ mice that are protected from PTA. CXCL10 protein expression was assessed in human cartilage in normal, osteoarthritic (OA), and post-traumatic tissue using immunohistochemistry. The effects of exogenous CXCL10, alone and in combination with IL-1, on porcine cartilage explants were assessed by quantifying the release of catabolic mediators. Synovial tissue gene expression of CXCL10 was upregulated by joint trauma, peaking one day in C57BL/6 mice (25-fold) vs. three days post-fracture in MRL/MpJ mice (15-fold). CXCL10 protein in articular cartilage was most highly expressed following trauma compared with normal and OA tissue. In a dose dependent manner, exogenous CXCL10 significantly reduced total matrix metalloproteinase (MMP) and aggrecanase activity of culture media from cartilage explants. CXCL10 also trended toward a reduction in IL-1α-stimulated total MMP activity (p=0.09) and S-GAG (p=0.09), but not NO release. In conclusion, CXCL10 was upregulated in synovium and chondrocytes following trauma. However, exogenous CXCL10 did not induce a catabolic response in cartilage. CXCL10 may play a role in modulating the chondrocyte response to inflammatory stimuli associated with joint injury and the progression of PTA. This article is protected by copyright. All rights reserved

Osteoarthritic Milieu Affects Adipose‐Derived Mesenchymal Stromal Cells

“…This trend was also confirmed using OA‐SF, suggesting the OA milieu and hypoxic condition‐induced GMP‐ASC migration, which could be mainly dependent on their specific ligands, CXCL10/IP10, CCL5/RANTES, CCL11/Eotaxin, and IL6 than by CXCL12/SDF‐1. A significant reduction of CXCL10/IP10 in the supernatant of GMP‐ASC treated with OA milieu suggests a direct involvement of the CXCL10/IP10–CXCR3 axis, as confirmed by blocking experiments, which has been recently reported as crucial axis in the severity of OA by regulating neutrophil‐NK cell cross‐talk . Indeed, CXCL10/IP10 was highly expressed by synovial macrophages, indicating that GMP‐ASC recruitment and homing to synovial macrophages, as previously demonstrated in OA animal model, could be partially dependent on CXCL10/IP10–CXCR3 axis.…”

Using diet-induced obesity to understand a metabolic subtype of osteoarthritis in rats

“…Furthermore, increased concentrations of 2 of the 27 serum markers (serum leptin and serum IP10/CXCL10) were significantly correlated with increased Modified Mankin scores in DIO animals. These markers have previously been implicated in OA 6,34,35 . Three synovial fluid mediators were elevated in DIO compared to LFD animals: leptin, IL-1a, IP10/CXCL10.…”

Monocyte/Macrophage Lineage Cells From Fetal Erythromyeloid Progenitors Orchestrate Bone Remodeling and Repair

“…DAMPs, including the high-mobility group box 1 (HMGB1) proteins, N-formyl peptides, S100 proteins, and heat shock proteins, are mainly recognized by the nucleotide oligomerization domain (NOD)-like receptors (NLRs) and toll-like receptors (TLRs) (Vourc'h et al, 2018 ; Relja and Land, 2020 ). Further, the neutrophils and other immune cells induce monocyte chemotaxis via the secretion of several CXC chemokine ligands (CXCL1, CXCL2, CXCL3, CXCL8, CXCL10, and CXCL12) (Kitaori et al, 2009 ; Kolar et al, 2011 ; Myers et al, 2015 ; Förster et al, 2016 ; Hoff et al, 2016 ; Furman et al, 2018 ; Burska et al, 2020 ) and CC chemokine ligands (CCL2, CCL3, CCL4, and CCL5)(Xing et al, 2010 ; Wu et al, 2013 ; Ishikawa et al, 2014 ; Hoff et al, 2016 ) during fracture healing.…”